Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0.626. It has been cited 64 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
Base Score Contribution
0.626
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology âLeukemia and Lymphoma Society
Grant: 2316-17
National Institutes of Health
Grant: R01 CA205954
Stand Up To Cancer
Grant: SU2C-AACR-CT05-17
NIGMS NIH HHS
Grant: T32 GM008313
NCI NIH HHS
Grant: R35 CA263817
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
International Waldenstrom's Macroglobulinemia Foundation
Minneapolis Medical Research Foundation
International Myeloma Society
Multiple Myeloma Research Foundation
FWCI
7.54
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals